Literature DB >> 22421409

Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes.

Ulrich Germing1, Corinna Strupp, Aristoteles Giagounidis, Rainer Haas, Norbert Gattermann, Carsten Starke, Carlo Aul.   

Abstract

Using the Düsseldorf MDS registry with standardized cytomorphology we here describe dysplastic features in detail, concentrating on 16 different dysplastic features in the blood and 19 in the marrow in 3156 patients. The most frequent dysplastic features were megaloblastoid changes and bi- and multinuclearity in the erythropoiesis, pseudo-Pelger cells and hypogranulation in the granulopoiesis and micromegakaryoctes and mononuclear megakaryocytes in the megakaryopoiesis. The frequency of dysplastic changes did not differ significantly among the WHO types with the exception of MDS with del(5q) and CMML types. No single sign of dysplasia is exclusive for the diagnosis of MDS.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22421409     DOI: 10.1016/j.leukres.2012.02.014

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  21 in total

1.  [Myelodysplastic syndromes].

Authors:  A Giagounidis
Journal:  Internist (Berl)       Date:  2013-06       Impact factor: 0.743

Review 2.  Molecular pathophysiology of myelodysplastic syndromes.

Authors:  R Coleman Lindsley; Benjamin L Ebert
Journal:  Annu Rev Pathol       Date:  2012-08-28       Impact factor: 23.472

3.  Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.

Authors:  Chun-Mei Fu; Zi-Xing Chen; Dan-Dan Liu; Jun Zhang; Jin-Lan Pan; Jian-Ying Liang
Journal:  Int J Hematol       Date:  2014-11-28       Impact factor: 2.490

4.  Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.

Authors:  Theresia M Westers; Eline M P Cremers; Uta Oelschlaegel; Ulrika Johansson; Peter Bettelheim; Sergio Matarraz; Alberto Orfao; Bijan Moshaver; Lisa Eidenschink Brodersen; Michael R Loken; Denise A Wells; Dolores Subirá; Matthew Cullen; Jeroen G Te Marvelde; Vincent H J van der Velden; Frank W M B Preijers; Sung-Chao Chu; Jean Feuillard; Estelle Guérin; Katherina Psarra; Anna Porwit; Leonie Saft; Robin Ireland; Timothy Milne; Marie C Béné; Birgit I Witte; Matteo G Della Porta; Wolfgang Kern; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

5.  Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Authors:  M G Della Porta; E Travaglino; E Boveri; M Ponzoni; L Malcovati; E Papaemmanuil; G M Rigolin; C Pascutto; G Croci; U Gianelli; R Milani; I Ambaglio; C Elena; M Ubezio; M C Da Via'; E Bono; D Pietra; F Quaglia; R Bastia; V Ferretti; A Cuneo; E Morra; P J Campbell; A Orazi; R Invernizzi; M Cazzola
Journal:  Leukemia       Date:  2014-05-20       Impact factor: 11.528

6.  Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.

Authors:  Leonor Senent; Leonor Arenillas; Elisa Luño; Juan C Ruiz; Guillermo Sanz; Lourdes Florensa
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

7.  Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.

Authors:  Eline M P Cremers; Theresia M Westers; Canan Alhan; Claudia Cali; Heleen A Visser-Wisselaar; Dana A Chitu; Vincent H J van der Velden; Jeroen G Te Marvelde; Saskia K Klein; Petra Muus; Edo Vellenga; Georgina E de Greef; Marie-Cecile C J C Legdeur; Pierre W Wijermans; Marian J P L Stevens-Kroef; Pedro da Silva-Coelho; Joop H Jansen; Gert J Ossenkoppele; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

Review 8.  Myelodysplastic syndromes: diagnosis, prognosis, and treatment.

Authors:  Ulrich Germing; Guido Kobbe; Rainer Haas; Norbert Gattermann
Journal:  Dtsch Arztebl Int       Date:  2013-11-15       Impact factor: 5.594

9.  Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Authors:  Zhongxun Shi; Tiejun Qin; Zefeng Xu; Bing Li; Huijun Huang; Hongli Zhang; Liwei Fang; Lijuan Pan; Naibo Hu; Shiqiang Qu; Gang Huang; Robert Peter Gale; Zhijian Xiao
Journal:  Leuk Lymphoma       Date:  2019-05-06

Review 10.  Importance of classical morphology in the diagnosis of myelodysplastic syndrome.

Authors:  Rosangela Invernizzi; Federica Quaglia; Matteo Giovanni Della Porta
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.